Toronto Dominion Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Toronto Dominion Bank’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.12K	Sell	17 -9,914	-100%	-$1.24M	﹤0.01%	2004
2025 Q4	$1.21M	Sell	9,931 -28,003	-74%	-$3.21M	﹤0.01%	1220
2025 Q3	$3.8M	Buy	37,934 +33,037	+675%	+$2.98M	0.01%	877
2025 Q2	$406K	Sell	4,897 -496	-9%	-$39.6K	﹤0.01%	1208
2025 Q1	$437K	Sell	5,393 -4,301	-44%	-$384K	﹤0.01%	1174
2024 Q4	$874K	Sell	9,694 -10,320	-52%	-$1,000K	﹤0.01%	1087
2024 Q3	$1.98M	Sell	20,014 -1,729	-8%	-$170K	﹤0.01%	764
2024 Q2	$2.02M	Buy	21,743 +3,048	+16%	+$273K	﹤0.01%	787
2024 Q1	$1.77M	Sell	18,695 -2,173	-10%	-$202K	﹤0.01%	795
2023 Q4	$1.86M	Buy	+20,868	New	+$1.55M	﹤0.01%	873
2023 Q3	–	Sell	-4,019	Closed	-$321K	–	1911
2023 Q2	$334K	Buy	+4,019	New	+$336K	﹤0.01%	1083
2023 Q1	–	Sell	-454,451	Closed	-$37.7M	–	1736
2022 Q4	$37.7M	Sell	454,451 -1,364,434	-75%	-$110M	0.06%	218
2022 Q3	$144M	Sell	1,818,885 -1,275,000	-41%	-$107M	0.26%	61
2022 Q2	$230M	Hold	3,093,885	–	–	0.43%	38
2022 Q1	$278M	Sell	3,093,885 -150	-0%	-$13.9K	0.42%	40
2021 Q4	$346M	Sell	3,094,035 -1,975,500	-39%	-$238M	0.46%	38
2021 Q3	$637M	Sell	5,069,535 -1,305,665	-20%	-$168M	1%	14
2021 Q2	$864M	Buy	6,375,200 +6,374,810	+1,634,567%	+$838M	1.34%	7
2021 Q1	$53K	Sell	390 -2,000	-84%	-$299K	﹤0.01%	1216
2020 Q4	$336K	Sell	2,390 -2,660	-53%	-$341K	﹤0.01%	985
2020 Q3	$563K	Buy	5,050 +5,000	+10,000%	+$561K	﹤0.01%	910
2020 Q2	$6K	Sell	50 -7,785	-99%	-$767K	﹤0.01%	1141
2020 Q1	$607K	Buy	7,835 +900	+13%	+$79.7K	﹤0.01%	838
2019 Q4	$659K	Sell	6,935 -12,345	-64%	-$1.07M	﹤0.01%	928
2019 Q3	$1.47M	Buy	19,280 +3,520	+22%	+$293K	﹤0.01%	894
2019 Q2	$692K	Buy	15,760 +14,910	+1,754%	+$1.27M	﹤0.01%	1030
2019 Q1	$77K	Hold	850	–	–	﹤0.01%	1252
2018 Q4	$61K	Sell	850 -200	-19%	-$16.1K	﹤0.01%	1219
2018 Q3	$100K	Sell	1,050 -2,100	-67%	-$204K	﹤0.01%	1127
2018 Q2	$300K	Hold	3,150	–	–	﹤0.01%	1091
2018 Q1	$277K	Sell	3,150 -3,900	-55%	-$356K	﹤0.01%	1019
2017 Q4	$598K	Sell	7,050 -581	-8%	-$48.7K	﹤0.01%	849
2017 Q3	$661K	Sell	7,631 -12,000	-61%	-$962K	﹤0.01%	730
2017 Q2	$1.51M	Sell	19,631 -13,269	-40%	-$941K	﹤0.01%	678
2017 Q1	$2.28M	Buy	32,900 +25,000	+316%	+$1.68M	0.01%	598
2016 Q4	$468K	Buy	7,900 +7,300	+1,217%	+$451K	﹤0.01%	758
2016 Q3	$40K	Hold	600	–	–	﹤0.01%	1055
2016 Q2	$33K	Hold	600	–	–	﹤0.01%	1006
2016 Q1	$31K	Hold	600	–	–	﹤0.01%	1009
2015 Q4	$42K	Hold	600	–	–	﹤0.01%	931
2015 Q3	$38K	Hold	600	–	–	﹤0.01%	916
2015 Q2	$50K	Hold	600	–	–	﹤0.01%	947
2015 Q1	$45K	Hold	600	–	–	﹤0.01%	930
2014 Q4	$37K	Hold	600	–	–	﹤0.01%	916
2014 Q3	$0	Hold	600	–	–	﹤0.01%	1049
2014 Q2	$31K	Hold	600	–	–	﹤0.01%	954
2014 Q1	$30K	Hold	600	–	–	﹤0.01%	952
2013 Q4	$26K	Hold	600	–	–	﹤0.01%	936
2013 Q3	$26K	Hold	600	–	–	﹤0.01%	674
2013 Q2	$21K	Buy	+600	New	+$21.1K	﹤0.01%	694

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Toronto Dominion Bank's XBI Position: Q1 2026 in Review

Toronto Dominion Bank reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 100% in Q1 2026, selling an estimated $1.24M and leaving 17 shares worth $2.12K. The position accounts for ﹤0.01% of the portfolio, ranked #2004.

Toronto Dominion Bank first reported a position in XBI in Q2 2013 and has held it in 50 quarters since. The position peaked at $864M in Q2 2021. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Toronto Dominion Bank held 17 shares of State Street SPDR S&P Biotech ETF worth $2.12K as of Q1 2026.
Toronto Dominion Bank sold 9,914 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $1.24M.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #2004 holding.
Toronto Dominion Bank first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 50 quarters since.
Toronto Dominion Bank's State Street SPDR S&P Biotech ETF position peaked at $864M in Q2 2021.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.